To Study the Efficacy & Safety of Oral NA-921 (Bionetide) in Girls and Women with Rett Syndrome
Clinical trial NCT06849973 · COMPLETED
Trial details
- NCT number
- NCT06849973
- Sponsor
- Biomed Industries, Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-15
- Primary completion
- 2024-11-22
- Enrollment
- 187
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.